| Luís Costa, Hospital de Santa Maria, Lisbon, Portugal |
| Chairs: Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain Ana Rita Sousa, Hospital de Santa Maria, Lisbon, Portugal |
|
| 15:05 - 15:25 | Improving survival in patients with brain metastases Nancy Lin, Harvard Medical School, Boston, USA |
| 15:25 - 15:45 | First-line in extensive visceral disease in triple-negative breast cancer Mafalda Oliveira, Hospital Universitario Vall d'Hebron, Barcelona, Spain |
| 15:45 - 16:05 | Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy Marion van Mackelenbergh, University Hospital Schleswig-Holstein, Kiel, Germany |
| 16:05 - 16:35 | Discussion |
| Chair: Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain |
|
| 16:50 - 17:20 | Translational chemical biology Gonçalo Bernardes, University of Cambridge, UK |
| 17:20 - 17:30 | Discussion |
| Chairs: Luís Costa, Hospital de Santa Maria, Lisbon, Portugal |
|
| 17:30 - 17:50 | Solving questions through academic clinical research Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain |
| 17:50 - 18:10 | Predicting response to neoadjuvant therapy in local-regional HER2-positive breast cancer Tomás Pascual, Hospital Clínic de Barcelona, Spain |
| 18:10 - 18:30 | Discussion |